The Council for Quality Respiratory Care (CQRC) commended lawmakers in the House Ways & Means Health Subcommittee for reviewing legislation to sustain and improve the Medicare program, including Patient Access to Durable Medical Equipment Act (PADME).
The PADME Act – bipartisan legislation widely supported by the respiratory care community – will extend the implementation of severe Medicare cuts to durable medical equipment (DME).
The PADME Act delays cuts to home oxygen supplies and services that began on January 1, and are scheduled for full implementation on July 1. The cuts are the result of the Centers for Medicare & Medicaid Services (CMS) applying competitive bid rates used in urban areas to rural and other non-competitive bid areas that Congress specifically excluded from the DME competitive program.
The CQRC warns that more time is needed to observe and analyze the impact of the cuts on beneficiary access before additional cuts take effect. While home oxygen leaders caution cuts could put access to high-quality and innovative home respiratory therapy at risk, they also warn cuts could result in higher overall Medicare spending due to increased hospital admissions.